#ICYMI: Check out this article by @BosBizAllison recapping one of Intellia’s 2020 announcements: receiving a grant from @gatesfoundation for a potential in vivo #sicklecelldisease treatment using #CRISPR/Cas9. https://t.co/ZJSyLVAAnP